COCP - Cocrystal Pharma, Inc.
1.065
0.035 3.286%
Share volume: 55,046
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.03
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-13-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 26.546 M | 21.573 M | 16.233 M | 10.659 M | 8.505 M | 10.446 M | |
| Current Assets | 24.492 M | 19.660 M | 14.256 M | 8.826 M | 6.765 M | 8.782 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 21.842 M | 18.143 M | 13.020 M | 6.921 M | 4.766 M | 7.729 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 244.000 K | 211.000 K | 181.000 K | 127.000 K | 107.000 K | 106.000 K | |
| Other Assets | 1.810 M | 1.702 M | 1.796 M | 1.706 M | 1.633 M | 1.558 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 26.546 M | 21.573 M | 16.233 M | 10.659 M | 8.505 M | 10.446 M | |
| Total liabilities | 3.961 M | 4.183 M | 3.530 M | 3.355 M | 3.172 M | 2.777 M | |
| Total current liabilities | 2.379 M | 2.654 M | 1.948 M | 1.931 M | 1.831 M | 1.520 M | |
| Accounts Payable | 2.139 M | 2.403 M | 1.655 M | 1.622 M | 1.514 M | 1.194 M | |
| Other liabilities | 1.582 M | 0.000 | 1.582 M | 0.000 | 1.341 M | 1.257 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.582 M | 0.000 | 1.582 M | 0.000 | 1.341 M | 1.257 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 22.585 M | 17.390 M | 12.703 M | 7.304 M | 5.333 M | 7.669 M | |
| Common stock | 342.455 M | 342.603 M | 342.855 M | 343.023 M | 343.107 M | 347.492 M | |
| Retained earnings | -319.870 M | -325.213 M | -330.152 M | -335.719 M | -337.774 M | -339.823 M |